2 completed, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Glipizide: new trials by email Literature Review of Glipizide trials Research Report on Glipizide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer Glipizide - Pancreatic Cancer, Pancreatic Carcinoma | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 29 | 2023-12-05 | 2026-08-06 |
| To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies Canakinumab 150 mg, Placebo to Canakinumab - Type 2 Diabetes Mellitus, Impaired Glucose Tolerance | Phase 2 | Completed | Novartis | 246 | 2010-02-01 | 2011-09-05 |
| Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients AZD1656, Placebo, Glipizide - Type II Diabetes Mellitus | Phase 2 | Completed | AstraZeneca | 530 | 2009-10-01 | 2012-11-26 |
Diabetes Mellitus, Type 2 (2) · Glucose Intolerance (1) · Metabolic Syndrome (1) · Pancreatic Neoplasms (1)
AstraZeneca (1) · Memorial Sloan Kettering Cancer Center (1) · Novartis (1)
Germany (2) · United States (2) · Australia (1) · Canada (1) · Chile (1) · Finland (1) · Hungary (1) · India (1) · Italy (1) · Latvia (1) · Lithuania (1) · Mexico (1) · Peru (1) · Poland (1) · Romania (1)
Azeez Farooki, MD (1) · Eva Johnsson (1) · John Wilding, DM FRCP (1)